| TI: |
Management of allergic rhinitis with a combination
antihistamine/anti-inflammatory agent. |
| TI: |
Effects of orally inhaled budesonide in seasonal allergic
rhinitis. |
| TI: |
Comparative study of terfenadine and cetirizine in hay fever:
assessment of efficacy and central nervous system effects. |
| TI: |
Cetirizine, loratadine, or placebo in subjects with seasonal
allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental
exposure unit. |
| TI: |
Hay fever: pharmacotherapy or immunotherapy? |
| TI: |
Efficacy, pharmacodynamics, and pharmacokinetics of CGP
51901, an anti-immunoglobulin E chimeric monoclonal antibody, in patients with seasonal
allergic rhinitis. |
| TI: |
Cetirizine treatment of rhinitis in children with pollen
allergy: evidence of its antiallergic activity. |
| TI: |
Azelastine nasal spray as adjunctive therapy to azelastine
tablets in the management of seasonal allergic rhinitis. |
| TI: |
Use of an anti-IgE humanized monoclonal antibody in
ragweed-induced allergic rhinitis. |
| TI: |
Fluticasone propionate aqueous nasal spray compared with oral
loratadine in patients with seasonal allergic rhinitis. |
| TI: |
Treatment with hot, humid air reduces the nasal response to
allergen challenge. |
| TI: |
Preseasonal intranasal immunotherapy in birch-alder allergic
rhinitis. A double-blind study. |
| TI: |
Brompheniramine, terfenadine, and placebo in allergic
rhinitis. |
| TI: |
Astemizole in combination with pseudoephedrine in the
treatment of seasonal allergic rhinitis. |
| TI: |
Efficacy and safety of mizolastine in seasonal allergic
rhinitis. The Rhinase Study Group. |